Last Update 21:18
Tuesday, 15 October 2019

Egypt starts distributing Hepatitis C drug

Health ministry starts distribution of Sovaldi to Hepatitis C patients

Ahram Online , Thursday 16 Oct 2014
hepatitis C
Sovaldi for curing hepatitis C (Photo courtesy of Gilead Sciences Inc.)
Views: 2904
Views: 2904

Egypt has started distributing Sovaldi, a drug for treating Hepatitis C.

Health Minister Adel Adawi announced at a press conference on Thursday that a new national plan was underway for the prevention of viral Hepatitis, which is rampant in Egypt.

The plan involves creating a database of patients in order to offer them future treatment strategies, and employing the latest treatment methods in hospitals.

Adawi had announced earlier that Egypt had received the first batch of Sovaldi – 50,000 doses - and his ministry was taking procedures to examine and distribute it. Media reports say that another 100,000 doses are expected by February.

Gilead Sciences will provide the drug for one percent of its market price, LE2,200 ($300), according to a previous statement by the health ministry.

Patients can register on a government website to receive the drug at their nearest medical centre. On 20 September, the ministry said over 171,000 people had registered to receive the drug.

Egypt has the highest rate of Hepatitis C in the world. Infections spiked from four percent in 1993 to 8.5 percent in 2005. The total estimated number of Egyptians infected is currently around 12 million.

In February, the Egyptian army claimed to have invented a device that detects and cures Hepatitis C. The claims were met with disbelief and ridicule by the international scientific community.

Short link:


Ahram Online welcomes readers' comments on all issues covered by the site, along with any criticisms and/or corrections. Readers are asked to limit their feedback to a maximum of 1000 characters (roughly 200 words). All comments/criticisms will, however, be subject to the following code
  • We will not publish comments which contain rude or abusive language, libelous statements, slander and personal attacks against any person/s.
  • We will not publish comments which contain racist remarks or any kind of racial or religious incitement against any group of people, in Egypt or outside it.
  • We welcome criticism of our reports and articles but we will not publish personal attacks, slander or fabrications directed against our reporters and contributing writers.
  • We reserve the right to correct, when at all possible, obvious errors in spelling and grammar. However, due to time and staffing constraints such corrections will not be made across the board or on a regular basis.

© 2010 Ahram Online.